David A. Reardon
Active 1997–2025
- Also published as
- David A Reardon
- 269
- Papers
- 56,227
- Citations
- 121
- h-index
- 257
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine63.3%
- Biochemistry, Genetics and Molecular Biology20.6%
- Immunology and Microbiology8.1%
- Neuroscience2.5%
- Engineering2.2%
- Materials Science1.3%
- Other2%
Topics
- Glioma Diagnosis and Treatment14.8%
- Cancer Immunotherapy and Biomarkers4.8%
- Brain Metastases and Treatment4.3%
- Immunotherapy and Immune Responses3.4%
- CAR-T cell therapy research2.6%
- Cancer, Hypoxia, and Metabolism2.5%
- Other67.6%
Coauthors
- Patrick Y. Wen75
- Henry S. Friedman56
- James E. Herndon47
- John H. Sampson45
- Allan H. Friedman43
- Annick Desjardins42
- James J. Vredenburgh42
- Darell D. Bigner36
- Roger E. McLendon36
- Michael Weller33
- Eudocia Q. Lee30
- Keith L. Ligon30
- Raymond Y. Huang29
- Timothy F. Cloughesy28
- Jeremy N. Rich27
- Wenya Linda Bi27
- Sridharan Gururangan25
- Lakshmi Nayak24
- Burt Nabors22
- Evanthia Galanis22
- Martin J. van den Bent22
- Jennifer A. Quinn21
- E. Antonio Chiocca19
- J. Bryan Iorgulescu19
All papers
- Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
Authors: David A. Reardon, Alba A. Brandes, Antonio Omuro, Paul Mulholland, Michael Lim, Antje Wick, Joachim M. Baehring, Manmeet S. Ahluwalia, Patrick Roth, Oliver Bähr, Surasak Phuphanich, Juan Manuel Sepúlveda-Sánchez, Paul de Souza, Solmaz Sahebjam, Michael Carleton, Kay Tatsuoka, Corina Taitt, Ricardo Zwirtes, John H. Sampson, Michael Weller - JAMA Oncology 2020 cited by 1,457
- IDH1andIDH2Mutations in Gliomas
Authors: Hai Yan, D. Williams Parsons, Genglin Jin, Roger E. McLendon, B. Ahmed Rasheed, Weishi Yuan, Ivan Kos, Ines Batinic̈‐Haberle, Siân Jones, Gregory J. Riggins, Henry S. Friedman, Allan H. Friedman, David A. Reardon, James E. Herndon, Kenneth W. Kinzler, Victor E. Velculescu, Bert Vogelstein, Darell D. Bigner - New England Journal of Medicine 2009 cited by 5,928
- Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Authors: Patrick Y. Wen, Michael Weller, Eudocia Q. Lee, Brian M. Alexander, Jill S. Barnholtz‐Sloan, Floris P Barthel, Tracy T. Batchelor, Ranjit S. Bindra, Susan M. Chang, E. Antonio Chiocca, Timothy F. Cloughesy, John DeGroot, Evanthia Galanis, Mark R. Gilbert, Monika E. Hegi, Craig Horbinski, Raymond Y. Huang, Andrew B. Lassman, Émilie Le Rhun, Michael Lim, Minesh P. Mehta, Ingo K. Mellinghoff, Giuseppe Minniti, David A. Nathanson, Michael Platten, Matthias Preusser, Patrick Roth, Marc Sanson, David Schiff, Susan Short, Martin Taphoorn, Joerg-Christian Tonn, Jonathan Tsang, Roel G.W. Verhaak, Andreas von Deimling, Wolfgang Wick, Gelareh Zadeh, David A. Reardon, Kenneth Aldape, Martin J. van den Bent - Neuro-Oncology 2020 cited by 1,137
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Authors: Derin B. Keskin, Annabelle Anandappa, Jing Sun, Itay Tirosh, Nathan D. Mathewson, Shuqiang Li, Giacomo Oliveira, Anita Giobbie‐Hurder, Kristen D. Felt, Evisa Gjini, Sachet A. Shukla, Zhuting Hu, Letitia Li, Phuong M. Le, Rosa Lundbye Allesøe, Alyssa Richman, Monika S. Kowalczyk, Sara Abdelrahman, Jack Geduldig, Sarah Charbonneau, Kristine Pelton, J. Bryan Iorgulescu, Liudmila Elagina, Wandi Zhang, Oriol Olive, Christine McCluskey, Lars Rønn Olsen, Jonathan Stevens, William J. Lane, Andres Μ. Salazar, Heather Daley, Patrick Y. Wen, E. Antonio Chiocca, Maegan Harden, Niall J. Lennon, Stacey Gabriel, Gad Getz, Eric S. Lander, Aviv Regev, Jerome Ritz, Donna Neuberg, Scott J. Rodig, Keith L. Ligon, Mario L. Suvà, Kai W. Wucherpfennig, Nir Hacohen, Edward F. Fritsch, Kenneth J. Livak, Patrick A. Ott, Catherine J. Wu, David A. Reardon - Nature 2018 cited by 1,464
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Authors: Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla, Willy Hugo, Alex Lee, Tom B. Davidson, Anthony Wang, Benjamin M. Ellingson, Julie Rytlewski, Catherine Sanders, Eric S. Kawaguchi, Lin Du, Gang Li, William H. Yong, Sarah Gaffey, Adam L. Cohen, Ingo K. Mellinghoff, Eudocia Q. Lee, David A. Reardon, Barbara O’Brien, Nicholas Butowski, Phioanh L. Nghiemphu, Jennifer Clarke, Isabel Arrillaga‐Romany, Howard Colman, Thomas Kaley, John de Groot, Linda M. Liau, Patrick Y. Wen, Robert M. Prins - Nature Medicine 2019 cited by 1,387
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Authors: Patrick Y. Wen, David R. Macdonald, David A. Reardon, Timothy F. Cloughesy, A. Gregory Sorensen, Evanthia Galanis, John DeGroot, Wolfgang Wick, Mark R. Gilbert, Andrew B. Lassman, Christina Tsien, Tom Mikkelsen, Eric T. Wong, Marc C. Chamberlain, Roger Stupp, Kathleen R. Lamborn, Michael A. Vogelbaum, Martin J. van den Bent, Susan M. Chang - Journal of Clinical Oncology 2010 cited by 3,829
- Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter
Authors: Michael Lim, Michael Weller, Ahmed Idbaïh, Joachim P. Steinbach, Gaetano Finocchiaro, Raju R. Raval, George Ansstas, Joachim M. Baehring, Jennie Taylor, Jérôme Honnorat, Kevin Petrecca, Filip De Vos, Antje Wick, Ashley Sumrall, Solmaz Sahebjam, Ingo K. Mellinghoff, Masashi Kinoshita, Mustimbo Roberts, Ruta Slepetis, Deepti Warad, David Leung, Michelle H. Lee, David A. Reardon, Antonio Omuro - Neuro-Oncology 2022 cited by 501
- Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial
Authors: Antonio Omuro, Alba A. Brandes, Alain Carpentier, Ahmed Idbaïh, David A. Reardon, Timothy F. Cloughesy, Ashley Sumrall, Joachim M. Baehring, Martin J. van den Bent, Oliver Bähr, Giuseppe Lombardi, Paul Mulholland, Ghazaleh Tabatabai, Ulrik Lassen, Juan Manuel Sepúlveda-Sánchez, Mustafa Khasraw, Élodie Vauléon, Yoshihiro Muragaki, Anna Maria Di Giacomo, Nicholas Butowski, Patrick Roth, Xiaozhong Qian, Alex Z. Fu, Yanfang Liu, Von Potter, Alexandros-Georgios Chalamandaris, Kay Tatsuoka, Michael Lim, Michael Weller - Neuro-Oncology 2022 cited by 485
- RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults
Authors: Patrick Y. Wen, Martin J. van den Bent, Gilbert Youssef, Timothy F. Cloughesy, Benjamin M. Ellingson, Michael Weller, Evanthia Galanis, Daniel P. Barboriak, John de Groot, Mark R. Gilbert, Raymond Y. Huang, Andrew B. Lassman, Minesh P. Mehta, Annette M. Molinaro, Matthias Preusser, Rifaquat Rahman, Lalitha Shankar, Roger Stupp, Javier Villanueva-Meyer, Wolfgang Wick, David R. Macdonald, David A. Reardon, Michael A. Vogelbaum, Susan M. Chang - Journal of Clinical Oncology 2023 cited by 462
- Clinical trial links oncolytic immunoactivation to survival in glioblastoma
Authors: Alexander Ling, Isaac H. Solomon, Ana Montalvo Landivar, Hiroshi Nakashima, Jared K. Woods, Andres Santos, Nafisa Masud, Geoffrey Fell, Xiaokui Mo, Ayse Selen Yilmaz, J. K. Grant, Abigail Zhang, Joshua D. Bernstock, Erickson Torio, Hirotaka Ito, Junfeng Liu, Naoyuki Shono, Michal O. Nowicki, Daniel Triggs, Patrick Halloran, Raziye Piranlioglu, Himanshu Soni, Brittany M. Stopa, Wenya Linda Bi, Pierpaolo Peruzzi, Ethan Chen, Seth Malinowski, Michael C. Prabhu, Yu Zeng, Anne E. Carlisle, Scott J. Rodig, Patrick Y. Wen, Eudocia Q. Lee, Lakshmi Nayak, Ugonma Chukwueke, L. Nicolas Gonzalez Castro, Sydney Dumont, Tracy T. Batchelor, Kara A. Kittelberger, Ekaterina Tikhonova, Natalia Miheecheva, D Tabakov, Nara Shin, Alisa M. Gorbacheva, Artemy Shumskiy, Felix Frenkel, Estuardo Aguilar-Córdova, Laura K. Aguilar, David Krisky, James Wechuck, Andrea G. Manzanera, Christopher Matheny, Paul P. Tak, Francesca Barone, Daniel Kovarsky, Itay Tirosh, Mario L. Suvà, Kai W. Wucherpfennig, Keith L. Ligon, David A. Reardon, E. Antonio Chiocca - Nature 2023 cited by 256
- Mechanisms and therapeutic implications of hypermutation in gliomas
Authors: Mehdi Touat, Yvonne Y. Li, Adam N. Boynton, Liam F. Spurr, J. Bryan Iorgulescu, Craig L. Bohrson, Isidro Cortés‐Ciriano, Cristina Birzu, Jack Geduldig, Kristine Pelton, Mary Jane Lim-Fat, Sangita Pal, Rubén Ferrer-Luna, Shakti Ramkissoon, Frank Dubois, Charlotte Bellamy, Naomi Currimjee, Juliana Bonardi, Kenin Qian, Patricia Ho, Seth Malinowski, Léon Taquet, Robert E. Jones, Aniket Shetty, Kin-Hoe Chow, Radwa Sharaf, Dean C. Pavlick, Lee A. Albacker, Nadia Younan, Capucine Baldini, Maïté Verreault, Marine Giry, Erell Guillerm, Samy Ammari, Frédéric Beuvon, Karima Mokhtari, Agustí Alentorn, Caroline Dehais, Caroline Houillier, Florence Laigle–Donadey, Dimitri Psimaras, Eudocia Q. Lee, Lakshmi Nayak, J Ricardo McFaline-Figueroa, Alexandre Carpentier, Philippe Cornu, Laurent Capelle, Bertrand Mathon, Jill S. Barnholtz‐Sloan, Arnab Chakravarti, Wenya Linda Bi, E. Antonio Chiocca, Katie Fehnel, Sanda Alexandrescu, N. Susan, Daphne A. Haas‐Kogan, Tracy T. Batchelor, Garrett M. Frampton, Brian M. Alexander, Raymond Y. Huang, Azra H. Ligon, Florence Coulet, Jean‐Yves Delattre, Khê Hoang‐Xuan, David M. Meredith, Sandro Santagata, Alex Duval, Marc Sanson, Andrew D. Cherniack, Patrick Y. Wen, David A. Reardon, Aurélien Marabelle, Peter J. Park, Ahmed Idbaïh, Rameen Beroukhim, Pratiti Bandopadhayay, Franck Bielle, Keith L. Ligon - Nature 2020 cited by 720
- Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39
Authors: Maisa C. Takenaka, Galina Gabriely, Veit Rothhammer, Iván Mascanfroni, Michael A. Wheeler, Chun‐Cheih Chao, Cristina Gutiérrez‐Vázquez, Jessica E. Kenison, Emily Tjon, Andréia Barroso, Tyler Vandeventer, Kalil Alves de Lima, Sonja Rothweiler, Lior Mayo, Soufiene Ghannam, Stéphanie Zandee, Luke M. Healy, David H. Sherr, Mauricio Farez, Alexandre Prat, Jack P. Antel, David A. Reardon, Hailei Zhang, Simon C. Robson, Gad Getz, Howard L. Weiner, Francisco J. Quintana - Nature Neuroscience 2019 cited by 526
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Authors: Roger Stupp, Monika E. Hegi, Thierry Gorlia, Sara Erridge, James Perry, Yong-Kil Hong, Kenneth Aldape, Benoît Lhermitte, Torsten Pietsch, Danica Grujičić, Joachim P. Steinbach, Wolfgang Wick, R. Tarnawski, Do‐Hyun Nam, Peter Hau, Astrid Weyerbrock, Martin J B Taphoorn, Chiung‐Chyi Shen, Nalini Rao, László Thurzó, Ulrich Herrlinger, Tejpal Gupta, Rolf‐Dieter Kortmann, Krystyna Adamska, Catherine McBain, Alba A. Brandes, J. C. Tonn, Oliver Schnell, Thomas Wiegel, Chae‐Yong Kim, Burt Nabors, David A. Reardon, Martin J. van den Bent, Christine Hicking, Andriy Markivskyy, Martin Picard, Michael Weller - The Lancet Oncology 2014 cited by 1,019
- Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Authors: Hussein A. Tawbi, Peter Forsyth, Alain P. Algazi, Omid Hamid, F. Stephen Hodi, Stergios J. Moschos, Nikhil I. Khushalani, Karl D. Lewis, Christopher D. Lao, Michael A. Postow, Michael B. Atkins, Marc S. Ernstoff, David A. Reardon, Igor Puzanov, Ragini R. Kudchadkar, Reena Thomas, Ahmad A. Tarhini, Anna C. Pavlick, Joel Jiang, Alexandre Avila, Sheena Demelo, Kim Margolin - New England Journal of Medicine 2018 cited by 1,321
- Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis
Authors: Nathan D. Mathewson, Orr Ashenberg, Itay Tirosh, Simon Gritsch, Elizabeth M. Perez, Sascha Marx, Livnat Jerby‐Arnon, Rony Chanoch-Myers, Toshiro Hara, Alyssa Richman, Yoshinaga Ito, Jason W. Pyrdol, Mirco Friedrich, Kathrin Schumann, Michael J. Poitras, Prafulla C. Gokhale, L. Nicolas Gonzalez Castro, Marni E. Shore, Christine Hebert, Brian Shaw, Heather L. Cahill, Matthew Drummond, Wubing Zhang, Olamide Olawoyin, Hiroaki Wakimoto, Orit Rozenblatt–Rosen, Priscilla K. Brastianos, Xia Liu, Pamela S. Jones, Daniel P. Cahill, Matthew P. Frosch, David N. Louis, Gordon J. Freeman, Keith L. Ligon, Alexander Marson, E. Antonio Chiocca, David A. Reardon, Aviv Regev, Mario L. Suvà, Kai W. Wucherpfennig - Cell 2021 cited by 412
- Molecular targeted therapy of glioblastoma
Authors: Émilie Le Rhun, Matthias Preusser, Patrick Roth, David A. Reardon, Martin J. van den Bent, Patrick Y. Wen, Guido Reifenberger, Michael Weller - Cancer Treatment Reviews 2019 cited by 724
- Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study
Authors: Hussein A Tawbi, Peter A Forsyth, F Stephen Hodi, Alain P Algazi, Omid Hamid, Christopher D Lao, Stergios J Moschos, Michael B Atkins, Karl Lewis, Michael A Postow, Reena P Thomas, John Glaspy, Sekwon Jang, Nikhil I Khushalani, Anna C Pavlick, Marc S Ernstoff, David A Reardon, Ragini Kudchadkar, Ahmad Tarhini, Caroline Chung, Corey Ritchings, Piyush Durani, Margarita Askelson, Igor Puzanov, Kim A Margolin - The Lancet Oncology 2021 cited by 322
- Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
Authors: Julie J. Miller, L. Nicolas Gonzalez Castro, Samuel K. McBrayer, Michael Weller, Timothy F. Cloughesy, Jana Portnow, Ovidiu C. Andronesi, Jill S. Barnholtz‐Sloan, Brigitta G. Baumert, Mitchel S. Berger, Wenya Linda Bi, Ranjit S. Bindra, Daniel P. Cahill, Susan M. Chang, J Costello, Craig Horbinski, Raymond Y. Huang, Robert B. Jenkins, Keith L. Ligon, Ingo K. Mellinghoff, Burt Nabors, Michael Platten, David A. Reardon, Diana D. Shi, David Schiff, Wolfgang Wick, Hai Yan, Andreas von Deimling, Martin J. van den Bent, William G. Kaelin, Patrick Y. Wen - Neuro-Oncology 2022 cited by 237
- Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
Authors: Lakshmi Nayak, Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot, Leia Nghiemphu, Thomas Kaley, Howard Colman, Christine McCluskey, Sarah Gaffey, Timothy R. Smith, David J. Coté, Mariano Severgnini, Jennifer H. Yearley, Qing Zhao, Wendy M. Blumenschein, Dan G. Duda, Alona Muzikansky, Rakesh K. Jain, Patrick Y. Wen, David A. Reardon - Clinical Cancer Research 2020 cited by 257
- Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
Authors: Shubham Pant, Martin Schüler, Gopa Iyer, Olaf Witt, Toshihiko Doi, Toshihiko Doi, Josep Tabernero, David A. Reardon, Christophe Massard, Anna Minchom, Iwona Ługowska, Omar Carranza, Dirk Arnold, Martin Gutierrez, Helen Winter, Kim Stuyckens, Lauren Crow, Saltanat Najmi, Constance Hammond, Shibu Thomas, Ademi Santiago-Walker, Spyros Triantos, Hussein Sweiti, Yohann Loriot, Omar Carranza, Martin Alberto Greco, Omar Carranza, Anthony M. Joshua, Christos S. Karapetis, Christopher D. Hart, Alison Y. Zhang, Hans Prenen, Jean‐Charles Goeminne, Jean‐Pascal Machiels, Sylvie Rottey, Marcelo Corassa, Graziela Zibetti Dal Molin, Katsuki Arima Tiscoski, Denis L. Jardim, Milena Perez Mak, Wei Fu, Herui Yao, Jing Huang, Haiping Jiang, Jing Huang, Baoshi Chen, Dong Yan, Yu Yang, Yohann Loriot, Christophe Le Tourneau, Nicolas Penel, Sébastien Salas, Jean‐Yves Blay, Pierre-Emmanuel Brachet, Xavier Durando, Sheik Emambux, Alain Ravaud, Gunnar Folprecht, Dirk Arnold, Martin Schüler, Marit Ahrens, Alexander Golf, Georg Martin Haag, Florian Lordick, Alexander Desuki, Marina Elena Cazzaniga, Fortunato Ciardiello, Michèle Milella, Takafumi Koyama, Yoshiki Hirooka, Wataru Okamoto, Kenjiro Aogi, Yasutoshi Kuboki, Jung-Yun Lee, Sung‐Bae Kim, Myung‐Ju Ahn, Jong Hee Chang, Yongman Kim, Do‐Hyun Nam, Jaesung Park, Iwona Ługowska, Luis Paz‐Ares, Víctor Moreno, Andrés Cervantes, Mariona Calvo, Alejandro Falcón, Antonio González, Josep Tabernero, A. Martinez Bueno, Javier García-Corbacho, Federico Longo, Chia‐Jui Yen, Jen‐Shi Chen, Ming‐Feng Hou, Yee Chao, Kun‐Ming Rau, Tai‐Jan Chiu, Yin‐Hsun Feng, Chih‐Hung Hsu, Wen‐Tsung Huang and 33 more - The Lancet Oncology 2023 cited by 200
- Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Authors: Hideho Okada, Michael Weller, Raymond Y. Huang, Gaetano Finocchiaro, Mark R. Gilbert, Wolfgang Wick, Benjamin M. Ellingson, Naoya Hashimoto, Ian F. Pollack, Alba A. Brandes, Enrico Franceschi, Christel Herold‐Mende, Lakshmi Nayak, Ashok Panigrahy, Whitney B. Pope, Robert M. Prins, John H. Sampson, Patrick Y. Wen, David A. Reardon - The Lancet Oncology 2015 cited by 763
- Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
Authors: Manmeet S. Ahluwalia, David A. Reardon, Ajay Abad, William T. Curry, Eric T. Wong, Sheila Figel, Laszlo Mechtler, David M. Peereboom, Alan D. Hutson, Henry Withers, Song Liu, Ahmed Belal, Jingxin Qiu, Kathleen Mogensen, Sanam Dharma, Andrew Dhawan, Meaghan Birkemeier, Danielle Casucci, Michael J. Ciesielski, Robert A. Fenstermaker - Journal of Clinical Oncology 2022 cited by 159
- Glial and myeloid heterogeneity in the brain tumour microenvironment
Authors: Brian M. Andersen, Camilo Faust Akl, Michael A. Wheeler, E. Antonio Chiocca, David A. Reardon, Francisco J. Quintana - Nature reviews. Cancer 2021 cited by 210
- Spatial maps of T cell receptors and transcriptomes reveal distinct immune niches and interactions in the adaptive immune response
Authors: Sophia Liu, J. Bryan Iorgulescu, Shuqiang Li, Mehdi Borji, Irving Barrera, Vignesh Shanmugam, Haoxiang Lyu, Julia W. Morriss, Zoe N. Garcia, Evan Murray, David A. Reardon, Charles H. Yoon, David A. Braun, Kenneth J. Livak, Catherine J. Wu, Fei Chen - Immunity 2022 cited by 138
